VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: j bayer who wrote (2385)	11/11/1997 10:20:00 PM
From: Tunica Albuginea	Read Replies (2) of 23519

JB, Re : "The way I see it their time before Viagra is released is limited. Their window of opportunity to get new ED troubled patients to try Muse is closing. ". I think you ar emaking the same fundamental mistake that many investors , current and future, in ED products are making: you are conssidering Vivus and the oral agents as COMPETING products when , AT BEST, they will be COMPEMENTARY. They are DIFFERENT. Their success will depend purely on thier own unique BIOLOGICAL/ CHEMICAL charcteristics, and there will be no amount of PR or Doctor pushing that is going to change that. Within on eyear we'll know what works, how and when and sales we'll go from here. The No 1 successful model tha I see, ( for truly impotent men, is Viagra WITH Muse. TA

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next